Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes

Biological Chemistry

Volumn 387, Issue 1, 2006, Pages 15-22

  Bachvarov, Dimcho ^a,b   Bachvarova, Magdalena ^b   Koumangaye, Rainelli ^a,b   Klein, Julie ^c   Pesquero, João Bosco ^d   Neau, Eric ^c   Bader, Michael ^e   Schanstra, Joost P ^c   Bascands, Jean Loup ^c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c INSERM   (France)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Bradykinin receptor; Kidney; Knockout mice; Microarray

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; KININ;

ANIMAL TISSUE; ARTICLE; DOWN REGULATION; GENE EXPRESSION; KIDNEY FUNCTION; KNOCKOUT MOUSE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KIDNEY; MICE; MICE, KNOCKOUT; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; UP-REGULATION;

ANIMALIA;

EID: 30644475473     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.004     Document Type: Article

References (37)

1. Alfie, M.E., Yang, X.P., Hess, F., and Carretero, O.A. (1996). Salt-sensitive hypertension in bradykinin B2 receptor knockout mice. Biochem. Biophys. Res. Commun. 224, 625-630.
2. Allen, T.J., Cao, Z., Youssef, S., Hulthen, U.L., and Cooper, M.E. (1997). Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies. Diabetes 46, 1612-1618.
3. 1 receptor promoter: no modification upon interleukin-1β or lipopolysaccaride induction. J. Cell. Biochem. 78, 278-296.
4. Austin, C.E., Faussner, A., Robinson, H.E., Chakravarty, S., Kyle, D.J., Bathon, J.M., and Proud, D. (1997). Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways. J. Biol. Chem. 272, 11420-11425.
5. 1 receptor gene: altered frequency of an allele in patients with a history of end stage renal failure. J. Am. Soc. Nephrol. 9, 598-604.
6. Beierwaltes, W.H., Carretero, O.A., and Scicli, A.G. (1988). Renal hemodynamics in response to a kinin analogue antagonist. Am. J. Physiol. 255, F408-F414.
7. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
8. Borkowski, J.A., Ransom, R.W., Seabrook, G.R., Trumbauer, M., Chen, H., Hill, R.G., Strader, C.D., and Hess, J.F. (1995). Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J. Biol. Chem. 270, 13706-13710.
9. Cebrian, C., Areste, C., Nicolas, A., Olive, P., Carceller, A., Piulats, J., and Meseguer, A. (2001). Kidney androgen-regulated protein interacts with cyclophilin B and reduces cyclosporine A-mediated toxicity in proximal tubule cells. J. Biol. Chem. 276, 29410-29419.
10. Cervenka, L., Vaneckova, I., Maly, J., Horacek, V., and El-Dahr, S.S. (2003). Genetic inactivation of the B2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor. J. Hypertens. 21, 1531-1538.
11. Couture, R. and Girolami, J.P. (2004). Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus. Eur. J. Pharmacol. 500, 467-485.
12. El-Dahr, S.S., Yosipiv, I.V., Lewis, L., and Mitchell, K.D. (1995). Role of bradykinin B2 receptors in the developmental changes of renal hemodynamics in the neonatal rat. Am. J. Physiol. 269, F786-F792.
13. El-Dahr, S.S., Figueroa, C.D., Gonzalez, C.B., and Muller-Esterl, W. (1997). Ontogeny of bradykinin B2 receptors in the rat kidney: implications for segmental nephron maturation. Kidney Int. 51, 739-749.
14. El-Dahr, S.S., Harrison-Bernard, L.M., Dipp, S., Yosipiv, I.V., and Meleg-Smith, S. (2000). Bradykinin B2 null mice are prone to renal dysplasia: gene-environment interactions in kidney development. Physiol. Genomics 3, 121-131.
15. Jaffa, A.A., Rust, P.F., and Mayfield, R.K. (1995). Kinin, a mediator of diabetes-induced glomerular hyperfiltration. Diabetes 44, 156-160.
16. Kakoki, M., Takahashi, N., Jennette, J.C., and Smithies, O. (2004). Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc. Natl. Acad. Sci. USA 101, 3302-3305.
17. Leeb-Lundberg, L.M., Kang, D.S., Lamb, M.E., and Fathy, D.B. (2001). The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains. J. Biol. Chem. 276, 8785-8792.
18. Leeb-Lundberg, L.M., Marceau, F., Müller-Esterl, W., Pettibone, D.J., and Zuraw, B.L. (2005). International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77.
19. Mage, M., Pecher, C., Neau, E., Cellier, E., Dos Reiss, M.L., Schanstra, J.P., Couture, R., Bascands, J.L., and Girolami, J.P. (2002). Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can. J. Physiol. Pharmacol. 80, 328-333.
20. Marceau, F (1995). Kinin B1 receptors: a review. Immunopharmacology 30, 1-26.
21. Marceau, F., Hess, J.F., and Bachvarov, D.R. (1998). The B1 receptors for kinins. Pharmacol. Rev. 50, 357-386.
22. Margolius, H.S. (1995). Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension 26, 221-229.
23. Marin-Castano, M.E., Schanstra, J.P., Praddaude, F., Pesquero, J.B., Ader, J.L., Girolami, J.P., and Bascands, J.L. (1998). Differential induction of functional B1-bradykinin receptors along the rat nephron in endotoxin induced inflammation. Kidney Int. 54, 1888-1898.
24. Okada, H., Watanabe, Y., Kikuta, T., Kobayashi, T., Kanno, Y., Sugaya, T., and Suzuki, H. (2004). Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J. Am. Soc. Nephrol. 15, 2404-2413.
25. Pesquero, J.B., Araujo, R.C., Heppenstall, P.A., Stucky, C.L., Suva, J.A. Jr., Walther, T., Oliveira, S.M., Pesquero, J.L., Paiva, A.C., Calixto, J.B., Lewin, G.R., and Bader, M. (2000). Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc. Natl. Acad. Sci. USA 97, 8140-8145.
26. Phagoo, S.B., Poole, S., and Leeb-Lundberg, L.M. (1999). Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1β shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol. Pharmacol. 56, 325-333.
27. Schafer, S., Schmidts, H.L., Bleich, M., Busch, A.E., and Linz, W. (2004). Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent. Br. J. Pharmacol. 143, 27-32.
28. Schanstra, J.P., Bataille, E., Marin Castano, M.E., Barascud, Y., Hirtz, C., Pesquero, J.B., Pecher, C., Gauthier, F., Girolami, J.P., and Bascands, J.L. (1998). The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-κB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J. Clin. Invest. 101, 2080-2091.
29. Schanstra, J.P., Alric, C., Marin-Castano, M.E., Girolami, J.P., and Bascands, J.L. (1999). Renal bradykinin receptors: localisation, transduction pathways and molecular basis for a possible pathological role. Int. J. Mol. Med. 3, 185-191.
30. 1 receptor-mediated changes in renal hemodynamics during endotoxin-induced inflammation. J. Am. Soc. Nephrol. 11, 1208-1215.
31. Schanstra, J.P., Neau, E., Drogoz, P., Arevalo Gomez, M.A., Lopez Novoa, J.M., Calise, D., Pecher, C., Bader, M., Girolami, J.P., and Bascands, J.L. (2002). In vivo bradykinin B2 receptor activation reduces renal fibrosis. J. Clin. Invest. 110, 371-379.
32. Soler, M., Tornavaca, O., Sole, E., Menoyo, A., Hardy, D., Catterall, J.F., Vandewalle, A., and Meseguer, A. (2002). Hormone-specific regulation of the kidney androgen-regulated gene promoter in cultured mouse renal proximal-tubule cells. Biochem. J. 366, 757-766.
33. Tan, Y., Wang, B., Keum, J.S., and Jaffa, A.A. (2005). Mechanisms through which bradykinin promotes glomerular injury in diabetes. Am. J. Physiol. Renal Physiol. 288, F483-R492.
34. Tanaka, R., Kon, V., Yoshioka, T., Ichikawa, I., and Fogo, A. (1994). Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int. 45, 537-543.
35. Uehara, Y., Hirawa, N., Numabe, A., Kawabata, Y., Ikeda, T., Gomi, T., Gotoh, A., and Omata, M. (1997). Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Am. J. Hypertens. 10, 83S-88S.
36. Vora, J.P., Oyama, T.T., Thompson, M.M., and Anderson, S. (1997). Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes. Diabetes 46, 107-112.
37. Yokota, K., Kishida, M., Ogura, T., Suzuki, J., Otsuka, F., Mimura, Y., Takeda, M., Nakamura, Y., and Makino, H. (2003). Role of bradykinin in renoprotective effects by angiotensin II type 1 receptor antagonist in salt-sensitive hypertension. Hypertens. Res. 26, 265-272.